NM_000232.5:c.21_23dupGGC

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_000232.5(SGCB):​c.21_23dupGGC​(p.Ala8dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000376 in 1,286,260 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00047 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00036 ( 0 hom. )

Consequence

SGCB
NM_000232.5 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7

Conservation

PhyloP100: 1.16
Variant links:
Genes affected
SGCB (HGNC:10806): (sarcoglycan beta) This gene encodes a member of the sarcoglycan family. Sarcoglycans are transmembrane components in the dystrophin-glycoprotein complex which help stabilize the muscle fiber membranes and link the muscle cytoskeleton to the extracellular matrix. Mutations in this gene have been associated with limb-girdle muscular dystrophy.[provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SGCBNM_000232.5 linkc.21_23dupGGC p.Ala8dup disruptive_inframe_insertion Exon 1 of 6 ENST00000381431.10 NP_000223.1 Q16585-1Q5U0N0
SGCBXM_047416074.1 linkc.21_23dupGGC p.Ala8dup disruptive_inframe_insertion Exon 1 of 5 XP_047272030.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SGCBENST00000381431.10 linkc.21_23dupGGC p.Ala8dup disruptive_inframe_insertion Exon 1 of 6 1 NM_000232.5 ENSP00000370839.6 Q16585-1
SGCBENST00000506357.5 linkn.6_8dupGGC non_coding_transcript_exon_variant Exon 1 of 5 5 ENSP00000421235.1 H0Y8J3

Frequencies

GnomAD3 genomes
AF:
0.000465
AC:
70
AN:
150688
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000971
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000661
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000934
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000215
AC:
8
AN:
37246
Hom.:
0
AF XY:
0.000281
AC XY:
6
AN XY:
21336
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000242
Gnomad ASJ exome
AF:
0.000584
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000237
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000162
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000364
AC:
413
AN:
1135466
Hom.:
0
Cov.:
31
AF XY:
0.000394
AC XY:
216
AN XY:
548178
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000227
Gnomad4 ASJ exome
AF:
0.000825
Gnomad4 EAS exome
AF:
0.0000403
Gnomad4 SAS exome
AF:
0.0000572
Gnomad4 FIN exome
AF:
0.0000847
Gnomad4 NFE exome
AF:
0.000396
Gnomad4 OTH exome
AF:
0.000354
GnomAD4 genome
AF:
0.000471
AC:
71
AN:
150794
Hom.:
0
Cov.:
32
AF XY:
0.000448
AC XY:
33
AN XY:
73678
show subpopulations
Gnomad4 AFR
AF:
0.000121
Gnomad4 AMR
AF:
0.0000660
Gnomad4 ASJ
AF:
0.000289
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000934
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000540
Hom.:
0
Bravo
AF:
0.000336
Asia WGS
AF:
0.000300
AC:
1
AN:
3340

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3
Mar 12, 2019
Athena Diagnostics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 29, 2022
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In-frame insertion of 1 amino acids in a repetitive region with no known function; Reported as a single heterozygous variant in a neonate with elevated creatine kinase levels (Mendell et al., 2012); This variant is associated with the following publications: (PMID: 22451200) -

Mar 03, 2016
Eurofins Ntd Llc (ga)
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.21_23dupGGC (p.A9dup) SGCB variant has been reported in individuals with elevated CK or LGMD, however little information was provided and other variants of unknown significance in other genes were noted.1,2 This variant has also been reported in the general population;3-6 however, the frequency data is insufficient to determine the clinical significance of this variant at this time. It is therefore classified as a variant of unknown significance. 1. Mendell et al. Ann Neurol. 2012 Mar;71(3):304-13. 2. www.lovd.nl/SGCB 3-6 pop db TMS 8-11-16 -

Autosomal recessive limb-girdle muscular dystrophy type 2E Uncertain:3
Nov 01, 2019
Natera, Inc.
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Oct 13, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant, c.21_23dup, results in the insertion of 1 amino acid(s) of the SGCB protein (p.Ala9dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has been observed in individual(s) with elevated creatine kinase levels (PMID: 22451200). ClinVar contains an entry for this variant (Variation ID: 193064). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Feb 25, 2022
Fulgent Genetics, Fulgent Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Uncertain:1
Jan 11, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: SGCB c.21_23dupGGC (p.Ala9dup) results in an in-frame duplication that is predicted to duplicate one amino acid into the encoded protein. The variant allele was found at a frequency of 0.00021 in 37246 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.21_23dupGGC has been reported in the literature in a newborn with elevated creatine kinase levels (Mendell_2012). This report does not provide unequivocal conclusions about association of the variant with Limb-Girdle Muscular Dystrophy, Autosomal Recessive. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 22451200). ClinVar contains an entry for this variant (Variation ID: 193064). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs768838951; hg19: chr4-52904402; API